SeQuent Scientific Issues 3,000 Shares Under ESOP 2020
By Shishta Dutta | Updated at: Jul 14, 2025 02:11 PM IST
Mumbai, June 18 — SeQuent Scientific Ltd (NSE: SEQUENT, BSE: 512529) announced the allotment of 3,000 equity shares under its ESOP 2020 plan. The shares carry equal rights to the existing shares and were allotted to one employee. The allotment occurred on June 17, 2025, and was as per SEBI (SBEB & SE) Regulations, 2021 (Regulation 10(c)).
This issuance was at an exercise price of ₹86 per share (Face value ₹2 each and Premium ₹84 each). The fresh ESOP allotments have strengthened internal trust and expanded the company’s presence in key global veterinary pharmaceutical markets. As of 2:45 PM today, the stock was trading at ₹194.62, down 0.06% from the previous close of ₹194.73.
Updated Capital Summary
| Particulars | Before Allotment | After Allotment |
|---|---|---|
| No. of Shares | 25,03,01,995 | 25,03,04,995 |
| Paid-Up Capital (₹) | ₹50,06,03,990 | ₹50,06,09,990 |
| Face Value Per Share (₹) | 2 | 2 |
ESOP Allotment Details
| Detail | Value |
|---|---|
| Number of Shares Allotted | 3,000 |
| Exercise Price (₹) | 86 |
| Premium Per Share (₹) | 84 |
| ISIN | INE807F01027 |
| Date of Issue | June 17, 2025 |
| Lock-in Period | Not Applicable |
Market Snapshot (as of 12:30 PM, June 18, 2025)
| Metric | Value |
|---|---|
| Last Traded Price | ₹194.62 |
| 52-Week High | ₹240.70 (Oct 1, 2024) |
| 52-Week Low | ₹116.40 (Jun 28, 2024) |
| Total Market Cap | ₹4,903.92 Cr |
| P/E Ratio (TTM) | 151.09 |
| Volume Traded Today | 5.49 lakh shares |
| VWAP | ₹193.97 |
| Daily Volatility (%) | 3.25 |
| Annualised Volatility (%) | 62.09 |
The stock has gained over 68% from its 52-week low, indicating strong investor sentiment despite a high trailing P/E.
Outlook
The ESOP issuance suggests internal confidence in long-term performance. SeQuent’s improving financial health, expanding margins, and steady global positioning in veterinary APIs highlight its strategic momentum. Continued delivery across its API and formulations business, especially in regulated markets, may support sustained market interest and long-term value creation.
About the Company
SeQuent Scientific Ltd is a publicly listed pharmaceutical company engaged in animal health APIs and formulations. Listed since March 2016, it is part of the NIFTY Total Market Index and maintains an active trading status.
REF: https://nsearchives.nseindia.com/corporate/SEQUENT1_18062025120228_ESOP_SE_intimation-_Alexis-.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
